Arama Sonuçları - T. M. Bukatina

Risk Management Plan: Expert Review of Applications for Marketing Authorisation in the EAEU Depending on the Type of Medicinal Product (Review) Yazar: T. M. Bukatina, E. V. Shubnikova

Connect to this object online.

Critical Overview of the Contents of Risk Management Plans for Medicines Yazar: T. M. Bukatina, E. V. Shubnikova

Connect to this object online.

Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document Yazar: T. M. Bukatina, E. V. Shubnikova

Connect to this object online.

Drug Safety Monitoring-International Information Yazar: E. V. Shubnikova, T. M. Bukatina, G. V. Kutekhova

Connect to this object online.

Canagliflozin and risk of amputation in patients with type 2 diabetes Yazar: T. M. Bukatina, A. S. Kazakov, D. A. Kaperko, T. V. Romanova

Connect to this object online.

Drug Safety Monitoring Information Yazar: Elena V. Shubnikova, Marya A. Darmostukova, Tatyana M. Bukatina

Connect to this object online.

Practical recommendations for screening of information on the drug safety Yazar: E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov

Connect to this object online.

Nonsteroidal anti-inflammatory drugs: problems of safe use Yazar: N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, G. V. Kutekhova

Connect to this object online.

Nicotine dependence and neuropsychotic effects of varenicline Yazar: T. M. Bukatina, A. S. Kazakov, R. N. Alyautdin, T. V. Romanova, I. I. Snegireva

Connect to this object online.

Rules of good laboratory practice: analysis of changes in the legislation Yazar: N. Yu. Velts, T. M. Bukatina, E. Yu. Pasternak, T. N. Nikolaeva, S. V. Romanova

Connect to this object online.

Ivermectin: Evaluation of Efficacy and Safety in COVID-19 Yazar: E. V. Shubnikova, N. A. Susekova, T. M. Bukatina, M. S. Galenko, A. A. Druzhinina

Connect to this object online.

The rules of good laboratory practice Yazar: N. Yu. Velts, R. N. Alyautdin, A. S. Kazakov, T. M. Bukatina, M. A. Darmostukova

Connect to this object online.

Comparative Analysis of International Databases of Adverse Drug Reactions Yazar: A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, N. Yu. Velts, R. N. Alyautdin

Connect to this object online.

Safety of apremilast: risk of psychical disorders Yazar: T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. Yu. Pasternak, T. V. Romanova

Connect to this object online.

Malaria and safety issues associated with antimalarial drugs Yazar: A. S. Kazakov, T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. O. Zhuravleva

Connect to this object online.

The risk management system as the important part of good pharmacovigilance practices (GVP) Yazar: A. S. Kazakov, K. E. Zatolochina, B. K. Romanov, T. M. Bukatina, N. Yu. Velts

Connect to this object online.

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents Yazar: E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko, G. V. Kutekhova

Connect to this object online.

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS Yazar: A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, I. I. Snegireva, V. K. Lepakhin, K. E. Zatolochina

Connect to this object online.

Safety of Antibacterial and Antiprotozoal Medicinal Products Yazar: E. V. Shubnikova, T. M. Bukatina, A. A. Druzhinina, E. O. Zhuravleva, G. V. Kutekhova, N. Yu. Velts

Connect to this object online.

Modern approaches to collecting and reporting information on side effects Yazar: K. E. Zatolochina, I. I. Snegireva, A. S. Kazakov, E. Yu. Kolesnikova, E. O. Zhuravleva, T. M. Bukatina, M. A. Darmostukova

Connect to this object online.